| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |